EHNA
 | |
| Systematic (IUPAC) name | |
|---|---|
|
3-(6-aminopurin-9-yl)nonan-2-ol hydrochloride | |
| Identifiers | |
| CAS Number | 59262-86-1 |
| PubChem | CID 359137 |
| ChEMBL |
CHEMBL50378  |
| Chemical data | |
| Formula | C14H24ClN5O |
| Molar mass | 313.826 g/mol |
| (verify) | |
EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]
References
- ↑ "Sigma Aldrich". Retrieved 16 January 2013.
- ↑ Podzuweit, T; Nennstiel, P; Muller, A (1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cell Signal 7 (7): 733–8. doi:10.1016/0898-6568(95)00042-N. PMID 8519602.
- ↑ Méry, PF; Pavoine, C; Pecker, F; Fischmeister, R (1995). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes". Mol Pharmacol 48 (1): 121–130. PMID 7623766.
This article is issued from Wikipedia - version of the Monday, June 16, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.